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Abstract
Acute viral myocarditis is one of the causes of heart failure. Car-
diac asthma is commonly observed in elderly patients with left 
heart failure. If the pulmonary manifestations are prominent it can 
mask the involvement of heart. We report a young case of viral 
myocarditis mimicking acute asthma attack. Case Presentation: A 
27-year-old young man with a history of asthma presented to the 
pulmonary department of our hospital with dyspnea, left sided chest 
pain, cough, wheezing. Asthma was diagnosed and treated, howev-
er his respiratory complaints have persisted. Laboratory evaluations 
revealed that elevated cardiac enzymes, Echocardiogram showed 
global hypokinesia in the left ventricle and a decrease of ejection 
fraction. We concluded that viral myocarditis can present itself like 
an acute asthma attack.
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Introduction
Myocarditis,  which  is  an  inflammatory  process  involving 
cardiac myocytes, can be induced by infections, immune-
mediated damage, or toxins. It can be defined on the basis 
of histopathologic or clinical criteria [1]. Amongst the in-
fectious causes, viral acute myocarditis is by far the most 
common [2]. In at least 10% of patients with viral infection, 
the virus may replicate in the heart [3]. Myocarditis gener-
ally results in a decrease in myocardial function, and this 
decrease may lead to pulmonary edema and congestive heart 
failure. Cardiac asthma is commonly observed in elderly pa-
tients with left heart failure. If the pulmonary manifestations 
are prominent it can mask the involvement of heart. We have 
reported a young case of myocarditis secondary to influenza 
a mimicking acute asthma attack for the first time.
Case Report
A 27-year-old young man presented to city hospital with 38 
°C fever, dyspnea, cough, wheezing and left sided chest pain. 
His complaints began after an episode of viral infection one 
week before his admission. Influenza antigen test for influen-
za A and Ig E antibody was positive. His skin allergy test was 
positive to dust mite. Chest radiography showed broncho-
vascular prominence (Fig. 1). Chest computed tomography 
also revealed bronchovascular prominence and pericardial 
minimal effusion (Fig. 2). He was diagnosed with asthma 
and acute viral bronchitis and pericarditis. He was treated 
by oseltamivir, bronchodilator and anti-inflammatory, but his 
respiratuar compliants persisted. He was referred to our hos-
pital two weeks later. His medical history revealed that his 
father had Wegener Diseases, and his mother had asthma. He 
has had symptoms of allergic rhinitis for two years but didn’t 
have diagnosis. He never smoked. On admission, the patient 
hemodynamic status was tachycardic as pulse 105 bpm and 
besides this, blood pressure was 110/70 mmHg, temperature 
37 °C and respiratory rate 20/min. White blood cell count, 
erythrocyte  sedimentation  rate,  C-reactive  protein  values 
were 21.7×109/L, 25 mm/h and 7.9 mg/L respectively on ad-
mission. He had elevated cardiac enzymes as troponin I 0.01 
μg/L, and CPK-MB 53 UI/L. C-ANCA was negative. Blood 
and sputum examination were all negative. Physical exami-
nation revealed that there were remarkable wheezes in both 
lungs and sinus tashicardia on auscultation. Electrocardio-
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graphic findings were nonspecific. Echocardiogram showed 
global hypokinesia in the left ventricular and a decrease of 
ejection fraction as 40%. After being started on diuretic and 
ACE inhibiteur therapy, the patient’s clinical condition sig-
nificantly improved. One month later control Echocardio-
gram showed significantly improvement in left ventricular 
systolic function as 57%.
Discussion
  
The clinical presentation of viral myocarditis varies from 
mild symptoms to acute hemodynamic compromise or sud-
den death [4]. Because of the variability of symptoms of 
acute  viral  myocarditis,  the  diagnosis  can  be  often-over-
looked. The onset of acute myocarditis starts on day 4 to 7 
of the onset of viral symptoms [5]. Pandemic Influenza A 
(H1N1) related myocarditis has been found more frequent 
than the seasonal influenza outbreaks before [6]. There is 
an increased risk of myocarditis for Influenza patients, and 
this should not be ignored. Also acute myocarditis has been 
reported at follow for patients with pericarditis and Cyto-
megalovirus and Epstein-Barr virus infection [7, 8]. There-
fore, patients with pericarditis and viral infection should be 
monitored more closely for myocarditis. 
Myocarditis is one of the causes of acute congestive 
heart failure (CHF) [9]. CHF presenting with wheezing is 
termed cardiac asthma and it seems generally in elderly pa-
tients [10]. The wheezes are a manifestation of tracheobron-
chial edema and often are accompanied by overt signs of 
pulmonary edema [11, 12]. Cardiac asthma has been never 
reported in young patients with viral myocarditis. Asthma 
has a clinical diagnosis that includes episodic dyspnea and 
wheezing attacks. Asthmatic patients are generally younger 
than CHF patients. Asthma has a heritable component. A 
positive family history, allergic status and positive skin test 
are helpful for diagnostic guides [13]. Nonasthmatic patients 
with allergic rhinitis often have bronchial hyperresponsive-
ness and asthma develops most commonly in patients with 
rhinitis than in those without [14, 15]. The developments of 
bronchial asthma come out from a complex interaction of 
genetic predisposition and environmental causes with viral 
infection likely playing a significant role in the effect of en-
vironment on asthma inception [16]. The patient had most of 
the characteristics above, as expected, were diagnosed with 
asthma. However, patients did not respond to treatment. For 
this reason, patients diagnosed with asthma after influenza 
infection should be examined in terms of myocarditis. Es-
pecially in cases that do not respond to treatment, it is more 
important. 
Conclusion
Viral myocarditis can present itself like an acute asthma at-
tack because of cardiac asthma and should be considered in 
the differential diagnosis of acute asthma attack in allergic 
patients with acute influenza infection. If there is compatible 
clinical picture, a recent viral infection should be considered 
in that it may cause acute myocarditis.
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